Literature DB >> 16750705

Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.

Henry G Riter, Margaret M Redfield, John C Burnett, Horng H Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16750705     DOI： 10.1016/j.jacc.2006.03.013

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  31 in total

Review 1.  Therapeutic adjustments in stage D heart failure: challenges and strategies.

Authors:  Emer Joyce; Anju Nohria
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Evolving treatment strategies for management of cardiorenal syndrome.

Authors:  Sanjay Dandamudi; Horng H Chen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 3.  Membrane guanylyl cyclase receptors: an update.

Authors:  David L Garbers; Ted D Chrisman; Phi Wiegn; Takeshi Katafuchi; Joseph P Albanesi; Vincent Bielinski; Barbara Barylko; Margaret M Redfield; John C Burnett
Journal:  Trends Endocrinol Metab       Date:  2006-06-30       Impact factor: 12.015

Review 4.  Nesiritide for acute decompensated heart failure: does the benefit justify the risk?

Authors:  Jonathan Sackner-Bernstein; Keith D Aaronson
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 5.  Nesiritide in acute decompensated heart failure: current status and future perspectives.

Authors:  Selma F Mohammed; Josef Korinek; Horng H Chen; John C Burnett; Margaret M Redfield
Journal:  Rev Cardiovasc Med       Date:  2008       Impact factor: 2.930

Review 6.  Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome.

Authors:  Ravi V Shah; Michael M Givertz
Journal:  Curr Heart Fail Rep       Date:  2009-09

7.  The tumultuous journey of nesiritide: past, present, and future.

Authors:  John C Burnett; Josef Korinek
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

8.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

9.  Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

10.  Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.

Authors:  H H Chen; F L Martin; R J Gibbons; J A Schirger; R S Wright; R M Schears; M M Redfield; R D Simari; A Lerman; A Cataliotti; J C Burnett
Journal:  Heart       Date:  2009-05-15       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.